American journal of obstetrics and gynecology

Am J Obstet Gynecol · ISSN (print) 0002-9378 · ISSN (e) 1097-6868 · 900 papers in corpus
article 2025
doi:10.1016/j.ajog.2025.12.036 ·PMID:41419153

BackgroundDespite widespread agreement that high-tone pelvic floor dysfunction is highly prevalent among women with pelvic pain, there is no consensus regarding standardized assessment strategy or diagnostic criteria. Furthermore, there are…

review 2025
doi:10.1016/j.ajog.2024.08.043 ·PMID:40253075

Single-cell technologies are expanding our understanding of endometriosis and adenomyosis, which are sister disorders of the uterine endometrium that contain similar complements of lesion cell types but in different locations-outside and in…

other 2025
doi:10.1016/j.ajog.2024.09.104 ·PMID:39357589
2025
doi:10.1016/j.ajog.2025.10.026 ·PMID:41135844

BackgroundMothers who experience major obstetrical syndromes (ie, preeclampsia, spontaneous preterm birth, fetal growth restriction, fetal death, and gestational diabetes mellitus) are at an increased risk for early death from cardiovascula…

2025
doi:10.1016/j.ajog.2024.09.117 ·PMID:39374749

BackgroundFertility success among mixed-sex couples often depends on frequency and timing of sexual intercourse, yet little research has evaluated the association between preconception sexual function and time-to-pregnancy.ObjectiveTo evalu…

other 2025
doi:10.1016/j.ajog.2025.02.033 ·PMID:39986340

BACKGROUND: Adenomyosis is a uterine disorder closely linked to infertility and adverse pregnancy outcomes. Despite its clinical significance, the mechanisms by which adenomyosis impairs embryo implantation and perinatal outcomes remain inc…

2025
doi:10.1016/j.ajog.2025.01.025 ·PMID:39863036

BackgroundMenstrual cycle characteristics are potential indicators of hormonal exposures and may also signal cardiovascular disease risk factors, both of which are relevant to cognitive health. However, there is scarce epidemiological evide…

other 2025
doi:10.1016/j.ajog.2025.03.002 ·PMID:40073916

BACKGROUND: Using menstrual products is a part of managing menstrual bleeding. Product use may represent individual, social, and economic influences. A few studies on menstrual product use from specific regions in the United States reported…

2025
doi:10.1016/j.ajog.2025.04.022 ·PMID:40254276

BackgroundSince professional societies recommended counseling patients about opportunistic salpingectomy for ovarian cancer risk reduction, use of opportunistic salpingectomy has increased overall. However, physicians varied in their adopti…

other 2025
doi:10.1016/j.ajog.2024.08.001 ·PMID:39127165

BACKGROUND: The prevalence of endometrial polyps among asymptomatic, postmenopausal women is not well defined. There is no clear clinical consensus on how to manage endometrial polyps in this population and whether these polyps truly are a …

2025
doi:10.1016/j.ajog.2024.08.041 ·PMID:40253074

Over the last decade, in line with the goals of precision medicine to offer individualized patient care, various single-cell technologies measuring gene and proteomic expression in various tissues have rapidly advanced to study health and d…

review 2025
doi:10.1016/j.ajog.2024.08.042 ·PMID:40253082

Cyclic exposure of the endometrium to ovarian sex steroids during the menstrual cycle induces a transition between proliferative and receptive states involving a different variety of cell types (ie, epithelial, stromal, endothelial, and imm…

review 2025
doi:10.1016/j.ajog.2024.05.046 ·PMID:40253085

The ovaries play a crucial role in both the endocrine health and fertility of adult women. The fundamental functional units of the ovaries, primordial follicles, form during fetal development and constitute the ovarian reserve. Ovaries age …

rct 2025
doi:10.1016/j.ajog.2024.07.006 ·PMID:39019388

BACKGROUND: Recent studies have shown that a disrupted microbiome is associated with endometriosis. Despite endometriosis affecting 1 in 10 reproductive-aged women, there is a lack of innovative and nonhormonal long-term effective treatment…

other 2025
doi:10.1016/j.ajog.2024.12.027 ·PMID:39736306

BACKGROUND: Endometriosis is a prevalent chronic gynecological condition characterized by severe pelvic pain, negatively affecting women's health-related quality of life. The Common-Sense Model of Illness Self-regulation has revealed the im…

review 2025
doi:10.1016/j.ajog.2025.10.007 ·PMID:41485855

Normal uterine function depends on cyclical regeneration and the capacity to sustain pregnancy. A cesarean incision represents an injury to this remarkable organ. Although the uterus possesses exceptional healing potential, cesarean deliver…

article 2025
doi:10.1016/j.ajog.2025.05.042 ·PMID:40482951
article 2025
doi:10.1016/j.ajog.2025.12.046 ·PMID:41423007
other 2025
doi:10.1016/j.ajog.2025.12.047 ·PMID:41423009
article 2024
doi:10.1016/j.ajog.2023.11.737
2024
doi:10.1016/j.ajog.2024.01.006 ·PMID:38219855

BackgroundThere is evidence suggesting that COVID-19 vaccination may be associated with small, transitory effects on uterine bleeding, possibly including menstrual timing, flow, and duration, in some individuals. However, changes in health …

article 2024
doi:10.1016/j.ajog.2024.04.030 ·PMID:38692470

BACKGROUND: Although endometriosis is a common condition-affecting ∼10% of premenopausal individuals-its etiology is unknown. Diet receives a lot of attention from patients, but studies of the role of diet are limited. Examining dietary pat…

other 2024
doi:10.1016/j.ajog.2024.05.029 ·PMID:38777162
2024
doi:10.1016/j.ajog.2024.02.282 ·PMID:38408622

BackgroundDiabetes is an independent risk factor for mesh complications in women undergoing mesh-augmented surgical repairs of stress urinary incontinence and/or pelvic organ prolapse. The underlying mechanism remains unclear.ObjectiveThis …

rct 2024
doi:10.1016/j.ajog.2024.06.040 ·PMID:38955323

BACKGROUND: Elagolix, an approved oral treatment for endometriosis-associated pain, has been associated with hypoestrogenic effects when used as monotherapy. Hormonal add-back therapy has the potential to mitigate these effects. OBJECTIVE:…